Search research articles
Contact Us
Filters
Showing results (311-320 of 455) with videos related to
Page
of 46
Sort By:
The Science of the Total Environment
|
July 2, 2019
Corrigendum to "A hybrid machine learning model to predict and visualize nitrate concentration throughout the Central Valley aquifer, California, USA" [Sci. Total Environ. (2017) 1160-1172]
Katherine M Ransom, Bernard T Nolan, Jonathan A Traum, et al.
Circulation
|
June 11, 2015
Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial
Sharon M Moe, Glenn M Chertow, Patrick S Parfrey, et al.
Circulation
|
July 14, 2018
Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney Disease
Richard Haynes, Parminder K Judge, Natalie Staplin, et al.
Diabetes Care
|
June 29, 2021
Efficacy and Safety of Dapagliflozin by Baseline Glycemic Status: A Prespecified Analysis From the DAPA-CKD Trial
Frederik Persson, Peter Rossing, Priya Vart, et al.
Kidney International
|
March 19, 2015
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Arlene B Chapman, Olivier Devuyst, Kai-Uwe Eckardt, et al.
The Lancet. Planetary Health
|
April 5, 2024
Ambient heat exposure and kidney function in patients with chronic kidney disease: a post-hoc analysis of the DAPA-CKD trial
Zhiyan Zhang, Hiddo J L Heerspink, Glenn M Chertow, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
June 29, 2023
Ferric Carboxymaltose in Iron-Deficient Patients with Hospitalized Heart Failure and Reduced Kidney Function
Iain C Macdougall, Piotr Ponikowski, Austin G Stack, et al.
JACC. Heart Failure
|
August 27, 2021
Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure
John J V McMurray, David C Wheeler, Bergur V Stefánsson, et al.
Journal of the American Society of Nephrology : JASN
|
July 17, 2021
Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease
Glenn M Chertow, Priya Vart, Niels Jongs, et al.
Journal of the American Society of Nephrology : JASN
|
April 10, 2015
Reduced Renal Methylarginine Metabolism Protects against Progressive Kidney Damage
James A P Tomlinson, Ben Caplin, Olga Boruc, et al.
Page
of 46
Search research articles
Search
Showing results (311-320 of 455) with videos related to
Sort By:
Page
of 46
The Science of the Total Environment
|
July 2, 2019
Corrigendum to "A hybrid machine learning model to predict and visualize nitrate concentration throughout the Central Valley aquifer, California, USA" [Sci. Total Environ. (2017) 1160-1172]
Katherine M Ransom, Bernard T Nolan, Jonathan A Traum, et al.
Circulation
|
June 11, 2015
Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial
Sharon M Moe, Glenn M Chertow, Patrick S Parfrey, et al.
Circulation
|
July 14, 2018
Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney Disease
Richard Haynes, Parminder K Judge, Natalie Staplin, et al.
Diabetes Care
|
June 29, 2021
Efficacy and Safety of Dapagliflozin by Baseline Glycemic Status: A Prespecified Analysis From the DAPA-CKD Trial
Frederik Persson, Peter Rossing, Priya Vart, et al.
Kidney International
|
March 19, 2015
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Arlene B Chapman, Olivier Devuyst, Kai-Uwe Eckardt, et al.
The Lancet. Planetary Health
|
April 5, 2024
Ambient heat exposure and kidney function in patients with chronic kidney disease: a post-hoc analysis of the DAPA-CKD trial
Zhiyan Zhang, Hiddo J L Heerspink, Glenn M Chertow, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
June 29, 2023
Ferric Carboxymaltose in Iron-Deficient Patients with Hospitalized Heart Failure and Reduced Kidney Function
Iain C Macdougall, Piotr Ponikowski, Austin G Stack, et al.
JACC. Heart Failure
|
August 27, 2021
Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure
John J V McMurray, David C Wheeler, Bergur V Stefánsson, et al.
Journal of the American Society of Nephrology : JASN
|
July 17, 2021
Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease
Glenn M Chertow, Priya Vart, Niels Jongs, et al.
Journal of the American Society of Nephrology : JASN
|
April 10, 2015
Reduced Renal Methylarginine Metabolism Protects against Progressive Kidney Damage
James A P Tomlinson, Ben Caplin, Olga Boruc, et al.
Page
of 46